# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder valu...
Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating addi...
On Monday, 369 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
Federal Funding Increases Fuel Research Progress and Help Improve Patient OutcomesLOS ANGELES, June 14, 2023 /PRNewswire/ -- Th...
Concurrently, the Company Announces $35 Million Financing of Convertible Preferred Stock at $4.00 per Share PharmaCyte Biotech...